论文部分内容阅读
目的探讨博利康尼联合酮替芬治疗小儿咳嗽变异性哮喘的临床效果。方法选取偃师市人民医院2011年6月至2011年12月收治的100例小儿咳嗽变异性哮喘患儿,按照不同的治疗手段将其随机分为观察组和对照组,对照组行常规治疗,观察组在原有的基础上采用博利康尼联合酮替芬治疗,观察两组患儿的治疗时间和效果以及后期的复发情况。结果对照组总有效率为88.0%,观察组为98.0%,观察组显著高于对照组,差异有统计学意义(P<0.05)。结论对于小儿咳嗽变异性哮喘采用博利康尼联合酮替芬治疗疗效显著,复发率低,具有临床价值意义,可以大力推广。
Objective To investigate the clinical efficacy of combination of blebicon and ketotifen in the treatment of children with cough variant asthma. Methods 100 children with cough variant asthma admitted from June 2011 to December 2011 in Yanshi People’s Hospital were randomly divided into observation group and control group according to different treatment methods. The control group received routine treatment, The observation group was treated with combination of boliconazole and ketotifen on the basis of the original, and the treatment time and effect of the two groups were observed as well as the recurrence later. Results The total effective rate of the control group was 88.0%, the observation group was 98.0%, the observation group was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion The treatment of varicocele cough with cough variability with tuberculosis combined with ketotifen significant effect, low recurrence rate, has clinical significance, can be vigorously promoted.